Voice your opinion on congressional bill S1897-116 and let lawmakers know your stance with UnPac!

Main Subject: Health

This bill authorizes the Food and Drug Administration (FDA) to require updates to outdated labels for certain generic drugs if the updates will provide a public health benefit. Generally, the FDA may use this authority to update the label of a generic version of a brand-name drug that has been withdrawn from the market for reasons other than safety or effectiveness.

HR5668-116, S1895-116,

Senate Actions

IntroReferral
Jun. 19 2019	Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Library of Congress Actions

IntroReferral
Jun. 19 2019	Introduced in Senate

Senate bill S1897-116

A bill to establish a process for updating the labeling of certain drugs with outdated labeling.

Senate bill S1897-116

A bill to establish a process for updating the labeling of certain drugs with outdated labeling.

Promote the cause!

Or use this QR code